Znn3bq.jpeg
ÉÇÍ·´óѧº£Ñó¿ÆÑ§½ÓÊܵ÷¼Á
²é¿´: 1046  |  »Ø¸´: 10
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

zhtear99

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)

[½»Á÷] FDA³ÆPradaxaÔÚÖÎÁÆÖзçʱÒý·¢µÄ³öѪ·çÏÕÓëwarfarinµÄÏà²îÎÞ¼¸ ÒÑÓÐ4È˲ÎÓë

Ô­ÎÄÁ´½Ó£º
http://medcitynews.com/2012/11/f ... arin/#ixzz2BEwbN7pM

The risk of serious bleeding among new users of Pradaxa, a blood-clot preventer made by Germany's BoehringerIngelheim, appeared to be no higher than in patients on the widely used standard blood thinner warfarin, U.S. regulators said.
ÃÀ¹ú¼à²ìÔ±Ö¸³ö£¬Óɵ¹úBoehringerIngelheim¹«Ë¾Ñз¢µÄѪ¿éÔ¤·ÀÒ©ÎïPradaxaÒý·¢µÄÑÏÖØ³öѪ·çÏÕ£¬Óë±»¹ã·ºÓ¦ÓõÄѪҺϡÊͼÁwarfarinµÄ£¨ÖÎÁÆ·çÏÕ£©ÊDz¶àµÄ¡£

The announcement Friday by the U.S. Food and Drug Administration may allay some safety concerns about Pradaxa, a pill developed by the privately held drugmakerBoehringer, to prevent strokes among patients with an irregular heartbeat known as atrial fibrillation.
ÖÜÎåµÄͨ¸æ±íÃ÷£¬FDA¿ÉÄÜ»á¼õÉÙ¶ÔPradaxa°²È«ÐÔÎÊÌâµÄ¹Ø×¢¡£PradaxaÊÇÓÉBoehringer¹«Ë¾¶À¼ÒÑз¢µÄ¿ÉÔ¤·ÀÐÄ·¿²ü¶¯£¨ÐÄÂÉʧ³££©²¡ÈËÖзçµÄÒ©Îï¡£

The regulator's findings were based on an assessment of insurance claims and other data.
Over the past year, the FDA has been analyzing reports of serious bleeding among patients prescribed Pradaxa, including gastrointestinal bleeding and bleeding in the brain.
¼à²ìÔ±µÄÕâЩ·¢ÏÖÊÇͨ¹ý¶ÔһЩ±£ÏÕË÷ÅâµÄ°¸ÀýºÍÆäËüһЩÊý¾Ý½øÐÐÆÀ¹ÀµÃµ½µÄ¡£ÔÚ¹ýÈ¥µÄÒ»ÄêÀFDA£¨¼à²ìÔ±£©ÒѾ­·ÖÎöÁ˲¡ÈËÒòPradaxaÖÎÁÆÒý·¢ÑÏÖØ³öѪµÄ±¨¸æ£¬°üÀ¨Î¸³¦µÀ³öѪºÍÄÔ³öѪ¡£

The agency said on Friday a comparable risk of serious bleeding for Pradaxa and warfarin was suggested by its review of insurance claims and by analyzing electronic healthcare data from multiple other sources.
ͨ¹ý·ÖÎö±£ÏÕË÷Åâ°¸ÀýºÍÔ´ÓÚ¶à¸öÇþµÀµÄµç×ÓÒ½ÁÆÊý¾Ý£¬FDAÓÚÖÜÎåÖ¸³öPradaxaºÍwarfarin£¨ÖÎÁÆÖзçʱ£©¿ÉÄÜÒý·¢µÄÑÏÖØ³öѪ·çÏÕÊÇÏà½üµÄ¡£

The FDA said it was also planning other assessments of Pradaxa's bleeding risks.
Õë¶ÔPradaxa£¨ÖÎÁÆÖз磩Òý·¢µÄ³öѪ·çÏÕ£¬FDAÉù³Æ»á¿¼ÂÇһЩÆäËûµÄÆÀ¹À·½°¸¡£

The medicine competes with Xarelto, a stroke-prevention pill for atrial fibrillation patients developed by Johnson & Johnson and Bayer AG. A similar pill being developed by Bristol-Myers Squibb and Pfizer Inc, Eliquis, is awaiting U.S. approval and is deemed by many Wall Street analysts to be the most impressive of a new generation of oral drugs to replace warfarin.
Pradaxa¿ÉÓëXareltoÏàæÇÃÀ£¬¶øºóÕßÊÇÓÉJohnson & JohnsonºÍBayer AG¹«Ë¾ÁªºÏÑз¢µÄÒ»ÖÖ¿ÉÓÃÓÚÔ¤·ÀÐÄ·¿²ü¶¯²¡ÈËÖзçµÄÒ©Îï¡£ÓÉBristol-Myers Squibb and Pfizer¹«Ë¾Ñз¢µÄEliquisÒ²ÊÇÒ»ÖÖÔ¤·ÀÖзçµÄÒ©ÎĿǰ¸ÃÒ©ÕýÔڵȴýFDAµÄÉóÅú¡£ÃÀ¹ú»ª¶û½Ö·ÖÎöÔ±ÈÏΪEliquisÔÚÈ¡´úwarfarinµÄÐÂÒ»´ú¿Ú·þÒ©ÎïÖÐ×îÁîÈËÖõÄ¿¡£

P.S.£º¸Ðлokitworks~
        Ë®Æ½ÓÐÏÞ£¬»¶Ó­´ó¼Ò¾À´í£¬Ò»Æð½»Á÷£¬»¥Ïàѧϰ~

[ Last edited by zhtear99 on 2012-11-5 at 08:09 ]
»Ø¸´´ËÂ¥

» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©

» ²ÂÄãϲ»¶

ÉúÊǹýÍù£¬°ÏÉæÐéÎÞÖ®¾³
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

zhtear99

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)

ÒýÓûØÌû:
2Â¥: Originally posted by ÁèÓîÀ×³Ø at 2012-11-05 08:04:28
ͽµÜºÜ¸øÁ¦ÍÛ\(^o^)/~

ºÙºÙ£¬Ð»Ð»Ê¦¸µ~
Ö÷ÒªÊÇÊܵ½¹Å¿ÉµÄÆô·¢ÁË~
ÉúÊǹýÍù£¬°ÏÉæÐéÎÞÖ®¾³
3Â¥2012-11-05 08:12:33
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 11 ¸ö»Ø´ð

ÁèÓîÀ׳Ø

³¬¼¶°æÖ÷ (ÎÄѧ̩¶·)

Сľ³æ¿ÆÑдóʹ\(^o^)/~

ÓÅÐãÇø³¤ÓÅÐãÇø³¤ÓÅÐãÇø³¤ÓÅÐãÇø³¤ÓÅÐãÇø³¤ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷

ͽµÜºÜ¸øÁ¦ÍÛ\(^o^)/~
ÉÏÉÆÈôË®\(^o^)/~2025\(^o^)/~
2Â¥2012-11-05 08:04:28
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÁèÓîÀ׳Ø

³¬¼¶°æÖ÷ (ÎÄѧ̩¶·)

Сľ³æ¿ÆÑдóʹ\(^o^)/~

ÓÅÐãÇø³¤ÓÅÐãÇø³¤ÓÅÐãÇø³¤ÓÅÐãÇø³¤ÓÅÐãÇø³¤ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷

ÒýÓûØÌû:
3Â¥: Originally posted by zhtear99 at 2012-11-05 08:12:33
ºÙºÙ£¬Ð»Ð»Ê¦¸µ~
Ö÷ÒªÊÇÊܵ½¹Å¿ÉµÄÆô·¢ÁË~...

°æ¿éÖ®ËùÒÔÉèÖÿÆÑпìѶ·ÖÀàµÄÄ¿µÄ¾ÍÊÇÕâÑùµÄ Ï£Íû´ó¼Ò¶¼ÒÔÕâÑùµÄģʽÀ´½»Á÷ºÍѧϰ\(^o^)/~ ͽµÜ×öµÄºÜºÃ¹þ\(^o^)/~
ÉÏÉÆÈôË®\(^o^)/~2025\(^o^)/~
4Â¥2012-11-05 08:24:03
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

¹Å¿É¤×

ÈÙÓþ°æÖ÷ (ÎÄ̳¾«Ó¢)

ÓÅÐãÇø³¤ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷

²»´í¡­Ð¡ÓãÀ÷º¦¡­¼ÌÐø¡£Ã¨½ã×Ô¼º±¾À´±ÈÕÔÇø»¹Ð¡Æø¡­ÎÒ·¢ÁËÁ½Æª¶¼ÊÇÁ½¸ö¡­ÕÔÇø¸øÎå¸öÊÇÄãµÄÁ½±¶°ë¡­»¹ºÃÒâ˼¶ßà¡­ßã¹þ¹þ¡­´þס»ú»áÄñ¡­¼ÇµÃ¸øÐ¡Óã²¹¸öepi@ringzhu [ ·¢×ÔÊÖ»ú°æ http://muchong.com/3g ]

[ Last edited by ¹Å¿É¤× on 2012-11-5 at 23:10 ]
·ÇÎáСÌìÏ£¬²Å¸ß¶øÒÑ£»·ÇÎá×ݹŽñ£¬Ê±¸³¶øÒÑ£»·ÇÎáíþ¾ÅÖÝ£¬ºê¹Û¶øÒÑ£»Èý·ÇÑÉ×ÎÞÃÎÖÁʤ
5Â¥2012-11-05 23:08:50
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 291·Öµ÷¼Á +8 Éϰ¶Ð¡Ó¨¼ÓÓÍ 2026-04-09 9/450 2026-04-15 00:41 by zzzggc
[¿¼ÑÐ] 291Çóµ÷¼Á +3 ¹ØÒä±±. 2026-04-14 3/150 2026-04-14 22:53 by Áº¼Òΰ
[»ù½ðÉêÇë] ɽ¶«Ê¡»ù½ð2026 +7 jerry681 2026-04-08 9/450 2026-04-14 22:01 by °¢ÓµÄÀºÇò
[¿¼ÑÐ] 290Çóµ÷¼Á +21 luoziheng 2026-04-10 23/1150 2026-04-14 15:49 by zs92450
[¿¼ÑÐ] 085404 298·ÖÇóµ÷¼Á +11 ºôÀ²ºôÀ²ºôºôºô 2026-04-10 12/600 2026-04-14 08:38 by wfj257
[¿¼ÑÐ] Çóµ÷¼Á +3 ÎÒ°®¸ßÊý¸ßÊý°®Î 2026-04-12 3/150 2026-04-14 01:00 by Íõ¬Bè±
[¿¼ÑÐ] Ò»Ö¾Ô¸Õã´óÉúÎï325·ÖÇóµ÷¼Á +9 zysheng 2026-04-12 9/450 2026-04-12 22:31 by yuyin1233
[¿¼ÑÐ] 344 ²ÄÁÏרҵ Çóµ÷¼Á211 ÎÞµØÓòÒªÇó +8 hualkop 2026-04-11 8/400 2026-04-12 22:24 by fqwang
[¿¼ÑÐ] µçÆø¹¤³Ìר˶320Çóµ÷¼Á +5 СÂé×Ó111 2026-04-10 5/250 2026-04-12 10:47 by zhouyuwinner
[¿¼ÑÐ] Ò»Ö¾Ô¸Î÷±±¹¤Òµ´óѧ289 085602 +33 yangæÃ 2026-04-10 34/1700 2026-04-12 08:11 by Art1977
[¿¼ÑÐ] Çóµ÷¼Á£¬262»úеר˶ +8 àÅyyl 2026-04-08 8/400 2026-04-12 02:31 by Çï¶¹²ËÑ¿
[¿¼ÑÐ] 303Çóµ÷¼Á +14 SereinQ 2026-04-10 15/750 2026-04-11 20:43 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 343Çóµ÷¼Á +9 Íõ¹ú˧ 2026-04-10 9/450 2026-04-11 20:31 by dongdian1
[¿¼ÑÐ] 0854µ÷¼Á +8 950824he@ 2026-04-09 8/400 2026-04-11 10:11 by zhq0425
[¿¼ÑÐ] 22408µ÷¼ÁÇóÖú +7 ì±12 2026-04-09 9/450 2026-04-11 09:23 by ŶŶ123
[¿¼ÑÐ] »¯Ñ§¹¤³ÌÓë¼¼Êõ324µ÷¼Á +23 Ëï³£»ª 2026-04-09 25/1250 2026-04-11 00:07 by ÆïÅ£¶Éº®½­
[¿¼ÑÐ] 263ÄÜÔ´¶¯Á¦×¨Ë¶Çóµ÷¼Á +3 ¼Ó´óºÅ·¹ºÐ´ü 2026-04-10 3/150 2026-04-10 22:23 by 286640313
[¿¼ÑÐ] 314Çóµ÷¼Á +14 weltZeng 2026-04-09 14/700 2026-04-09 23:14 by wolf97
[¿¼ÑÐ] 283µç×ÓÐÅÏ¢Çóµ÷¼Á +4 ÈýʯWL 2026-04-08 4/200 2026-04-09 10:21 by wp06
[¿¼ÑÐ] 286Çóµ÷¼Á +19 Faune 2026-04-08 20/1000 2026-04-09 08:36 by ŶŶ123
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û